p38 MAPK inhibition reduces diabetes-induced impairment of wound healing

Código QR

p38 MAPK inhibition reduces diabetes-induced impairment of wound healing

Satyanarayana Medicherla1, Scott Wadsworth2, Breda Cullen3, Derek Silcock3, Jing&nbsp;Y Ma1, Ruban Mangadu1, Irene Kerr1, Sarvajit Chakravarty1, Gregory L Luedtke1, Sundeep Dugar1, Andrew A Protter1, Linda S Higgins11Scios Inc., Fremont, CA, USA; 2Center for Biomaterials and Advanced Technol...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Satyanarayana Medicherla, Scott Wadsworth, Breda Cullen, Derek Silcock, et al.
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/d66217c22bda46f580f546002150d748
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Topical alpha-selective p38 MAP kinase inhibition reduces acute skin inflammation in guinea pig
por: Satyanarayana Medicherla, et al.
Publicado: (2010)

Effects of Topical Insulin on Wound Healing: A Review of Animal and Human Evidences
por: Wang J, et al.
Publicado: (2020)

Insulin, but Not Metformin, Supports Wound Healing Process in Rats with Streptozotocin-Induced Diabetes
por: Mieczkowski M, et al.
Publicado: (2021)

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment
por: Scott D
Publicado: (2013)

Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review
por: Holmes C, et al.
Publicado: (2013)

RPS4Y1 Promotes High Glucose-Induced Endothelial Cell Apoptosis and Inflammation by Activation of the p38 MAPK Signaling
por: Chen Y, et al.
Publicado: (2021)

Amantadine reduces glucagon and enhances insulin secretion throughout the oral glucose tolerance test: central plus peripheral nervous system mechanisms
por: Fuad Lechin, et al.
Publicado: (2009)

High Glucose Downregulates Connexin 43 Expression and Its Gap Junction and Hemichannel Function in Osteocyte-like MLO-Y4 Cells Through Activation of the p38MAPK/ERK Signal Pathway
por: Yang L, et al.
Publicado: (2020)

Retrospective study on the efficacy of a low-carbohydrate diet for impaired glucose tolerance
por: Maekawa S, et al.
Publicado: (2014)

Forsythoside A Alleviates High Glucose-Induced Oxidative Stress and Inflammation in Podocytes by Inactivating MAPK Signaling via MMP12 Inhibition
por: Quan X, et al.
Publicado: (2021)

miRNA-221-3p in Endothelial Progenitor Cell-Derived Exosomes Accelerates Skin Wound Healing in Diabetic Mice
por: Xu J, et al.
Publicado: (2020)

Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin
por: Russo E, et al.
Publicado: (2013)

Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity
por: Joharapurkar AA, et al.
Publicado: (2014)

Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
por: Duckett SK, et al.
Publicado: (2014)

Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol® on glycemic control of subjects with impaired fasting glucose
por: Evans M, et al.
Publicado: (2015)

Strategies for reducing body fat mass: effects of liposuction and exercise on cardiovascular risk factors and adiposity
por: Benatti FB, et al.
Publicado: (2011)

Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico
por: Hirales-Tamez O, et al.
Publicado: (2012)

Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice
por: Mashitah MW, et al.
Publicado: (2015)

Interaction between leucine and phosphodiesterase 5 inhibition in modulating insulin sensitivity and lipid metabolism
por: Fu L, et al.
Publicado: (2015)

Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors
por: Helena Escuin-Ordinas, et al.
Publicado: (2016)

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
por: Zambad SP, et al.
Publicado: (2013)

Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes
por: Galina Smushkin, et al.
Publicado: (2009)

Plausible relationship between homocysteine and obesity risk via MTHFR gene: a meta-analysis of 38,317 individuals implementing Mendelian randomization
por: Fu L, et al.
Publicado: (2019)

Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus
por: Whaley JM, et al.
Publicado: (2012)

Optimizing weight control in diabetes: antidiabetic drug selection
por: S Kalra, et al.
Publicado: (2010)

MicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy
por: Zhang D, et al.
Publicado: (2019)

Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-&kappa;B suppression
por: Sirada Rungseesantivanon, et al.
Publicado: (2010)

Past, present, and future: Critical analysis of use of gastric bands in obese patients
por: Brad Snyder, et al.
Publicado: (2010)

Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes
por: Priyanka Gunasekara, et al.
Publicado: (2011)

A molecular mechanism for diacylglycerol-mediated promotion of negative caloric balance
por: Hidekatsu Yanai, et al.
Publicado: (2009)

Anthropometric cutoff values for detecting metabolic abnormalities in Jordanian adults
por: Yousef S Khader, et al.
Publicado: (2010)

Association of adiponectin levels and insulin demand in critically ill patients
por: Andreas Hillenbrand, et al.
Publicado: (2011)

Relationships between fat deposition in the liver and skeletal muscle and insulin sensitivity in Japanese individuals: a pilot study
por: Eiichi Yoshimura, et al.
Publicado: (2011)

Evaluation of single nucleotide polymorphisms of Pro12Ala in peroxisome proliferator-activated receptor-&gamma; and Gly308Ala in tumor necrosis factor-&alpha; genes in obese Asian Indians: a population-based study
por: Namita Bhagat, et al.
Publicado: (2010)

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
por: Alaa Badawi, et al.
Publicado: (2010)

Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism
por: Mauro AM Carai, et al.
Publicado: (2009)

Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment
por: B Shariat-Madar, et al.
Publicado: (2010)

TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
por: Shitalkumar P Zambad, et al.
Publicado: (2011)

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
por: Michael A Via, et al.
Publicado: (2010)

Lifestyle modification in the management of the metabolic syndrome: achievements and challenges
por: Riccardo Dalle Grave, et al.
Publicado: (2010)